A322510 Share Price Performance
₩0
-6530.00 (-100.00%)
Price ₩0
Share Pricen/a
Is JLK (KOSDAQ:322510) Using Too Much Debt?
Dec 07
JLK, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A322510 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
JLK, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -535.97
- 97.76%
- -407.43%
- 72.6%
About A322510
- Founded
- 2014
- Employees
- 71
- CEO
- WebsiteView website
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.
